It is commonly prescribed to prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and to treat or prevent deep vein thrombosis (DVT) and pulmonary embolism (PE)
Our data showed that increased oxidative stress and mitochondrial dysfunction were involved in the pathogenesis of Fabry disease and were not fully eliminated even with ERT
Pathophysiology and treatment of cystinuria
GLP-1 use is safe and effective with many pre-existing conditions with the exception of the following: Currently pregnant Currently breastfeeding Currently being treated for cancer Active eating disorder Active gallbladder disease Active substance abuse or dependency Type 1 diabetes Bariatric surgery (within the past 18 months) Pancreatitis within the past 6 months, or a history of pancreatiitis caused by taking a GLP-1 Personal or family history of medullary thyroid cancer or MEN syndrome Personal history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
10.3389/fphar.2020.00425 Summary Keywords acute kidney injury, chuan huang fang, chronic kidney disease, renal fibrosis, reduced glutathione, traditional Chinese medicine Citation Chen L, Ye Z, Wang D, Liu J, Wang Q, Wang C, Xu B and Gong X (2022) Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 12) on chronic kidney disease (stages 24): A multicenter randomized controlled clinical trial
